Clicky

Covalon Technologies Ltd.(COV)

Description: Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating technology. The collagen matrix platform is used to manufacture products that treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns. The antimicrobial silicone adhesive platform is the basis for a range of pre-surgical, post surgical and vascular access products that are designed to kill any bacteria or yeast that comes into contact with the antimicrobial silicone. The coating technology is a grafting from process, which utilizes photo-polymerization to create active grafting sites.


Keywords: Medicine Surgery Infection Silicone Wound Bacteria Ulcer Silicon Burns Collagen Antimicrobial Platform Technologies Polymerization Venous Ulcer Pressure Ulcer Pressure Ulcers Coating Technology Infection Management

Home Page: www.covalon.com

COV Technical Analysis

1660 Tech Avenue
Mississauga, ON L4W 5S7
Canada
Phone: 905 568 8400


Officers

Name Title
Mr. Brian E. Pedlar Pres, CEO & Director
Simon Smith Chief Exec. Officer of Covalon Technologies (Europe) Ltd.
Gerry Arambula Pres of Covalon Technologies AG Ltd.
Dr. Valerio DiTizio Co-Founder, Chief Scientific Officer & VP
Mr. Jason F. Gorel Interim Chief Financial Officer
Ms. Elaine Zhang VP of Operations
Mr. Ron Hebert Sr. VP of Marketing
Mr. Greg Leszczynski VP of HR
Mr. Mark Doolittle Sr. VP of Commercial Sales
Mr. Hamed Abbasian VP of Bus. Devel.

Exchange: V

Country: CA : Canada

Currency: Canadian Dollar (C$)

Forward PE: 0
Trailing PE: 41.1667
Price-to-Book MRQ: 2.1895
Price-to-Sales TTM: 2.954
IPO Date:
Fiscal Year End: September
Full Time Employees: 0
Back to stocks